PARP1-mediated PARylation activity is essential for oligodendroglial differentiation and CNS myelination
Autor: | Vanessa Hull, Sheng Zhang, Maria Gregory, Preeti Prabhu, Yan Wang, Bokyung Kim, Verónica Martínez-Cerdeño, Xinhua Zhan, Wenbin Deng, Jie Xu, Yanhong Zhang, Fuzheng Guo |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
Central Nervous System
Male Medical Physiology Poly (ADP-Ribose) Polymerase-1 Neurodegenerative Inbred C57BL Regenerative Medicine PARP1 Mice Poly ADP Ribosylation Myelin Biology (General) Myelin Sheath Derepression Mice Knockout oligodendrocyte progenitor cells myelination Cell Differentiation Cell biology Oligodendroglia medicine.anatomical_structure oligodendrocytes (OLs) Neurological Female Stem Cell Research - Nonembryonic - Non-Human demyelination OPC differentiation Multiple Sclerosis Cell Survival QH301-705.5 Knockout 1.1 Normal biological development and functioning Central nervous system oligodendrocytes Nerve Tissue Proteins Biology Autoimmune Disease General Biochemistry Genetics and Molecular Biology Cuprizone Underpinning research medicine Animals PARG Remyelination Oligodendrocyte Precursor Cells Multiple sclerosis Regeneration (biology) Neurosciences Oligodendrocyte Transcription Factor 2 Stem Cell Research medicine.disease Oligodendrocyte Brain Disorders Mice Inbred C57BL Repressor Proteins PARylation stomatognathic diseases remyelination nervous system RNA oligodendrocyte progenitor cells (OPCs) Biochemistry and Cell Biology |
Zdroj: | Cell Reports, Vol 37, Iss 1, Pp 109695-(2021) Cell reports, vol 37, iss 1 |
ISSN: | 2211-1247 |
Popis: | Summary: The function of poly(ADP-ribosyl) polymerase 1 (PARP1) in myelination and remyelination of the central nervous system (CNS) remains enigmatic. Here, we report that PARP1 is an intrinsic driver for oligodendroglial development and myelination. Genetic PARP1 depletion impairs the differentiation of oligodendrocyte progenitor cells (OPCs) into oligodendrocytes and impedes CNS myelination. Mechanistically, PARP1-mediated PARylation activity is not only necessary but also sufficient for OPC differentiation. At the molecular level, we identify the RNA-binding protein Myef2 as a PARylated target, which controls OPC differentiation through the PARylation-modulated derepression of myelin protein expression. Furthermore, PARP1’s enzymatic activity is necessary for oligodendrocyte and myelin regeneration after demyelination. Together, our findings suggest that PARP1-mediated PARylation activity may be a potential therapeutic target for promoting OPC differentiation and remyelination in neurological disorders characterized by arrested OPC differentiation and remyelination failure such as multiple sclerosis. |
Databáze: | OpenAIRE |
Externí odkaz: |